全球临床化学市场 – 行业趋势和 2029 年预测

市场分析和规模

近几十年来，由于重大技术突破和医疗保健业务需求的不断增长，临床化学分析仪越来越受欢迎。临床化学专注于检查体内体液并提供精确的诊断信息。现代临床化学建立在传统手动实验室测试的基础上。然而，随着技术的进步，测试方法也得到了发展，现在可以使用化学分析仪等复杂设备在自动化实验室中进行各种测试。

Data Bridge Market Research 分析，临床化学市场在 2021 年为 130 亿美元，到 2029 年将飙升至 195.8 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 5.25%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

Market Definition

Chemical techniques are used in clinical chemistry to determine the amounts of chemical components in body fluids. It is a branch of biochemistry that deals with the diagnostic evaluation of bodily fluids. Clinical chemistry is used to diagnose diseases, determine metabolic function, and assess the presence of medications by evaluating serum, blood, cerebrospinal fluids, plasma, and urine samples for analyte concentration.

Clinical Chemistry Market Dynamics

Drivers

• Rise in demand of clinical chemistry

In the forecast period of 2022-2029, rising demand for POCT kits and analysers for rapid detection, rising occurrences of cardiovascular disorders, diabetes, hypertension, and others, rising preferences for automated devices, and increasing government initiatives for the prevalence of better healthcare diagnostics facilities are expected to accelerate the growth of the clinical chemistry market. On the other hand, the growing number of research activities will enhance numerous prospects, resulting in the clinical chemistry market growing during the projection period.

• Rise in the geriatric population

The rising prevalence rates of lifestyle disorders like diabetes and obesity, rising healthcare spending, and the fast-growing diagnostic industry drive the worldwide clinical chemistry market expansion. In addition, the growing elderly population, increased demand for laboratory automation, and more awareness of preventative healthcare are all driving the clinical chemistry market forward.

• Prevalence of chronic ailments

The rise of clinical chemistry has recently been fueled by an increase in the frequency of chronic diseases such as cancer and diabetes, which has resulted in increased demand for faster diagnosis, technological innovations, and scientific research for future therapeutic applications. The developments give benefits such as easy parameter monitoring, automatic data gathering, and automatic variable modifications, to name a few. The whole clinical chemistry market is expected to rise in the future as healthcare and medical professionals need more automated clinical chemistry procedures. In addition, the clinical chemistry business is seeing growing demand due to rising disposable incomes and increased awareness of the need of diagnostic examinations.

Opportunities

The total clinical chemistry market is predicted to grow in the future due to an increased desire for automated clinical chemistry techniques among healthcare and medical professionals. In the coming years, government initiatives and actions to promote clinical chemistry's benefits could potentially help boost the clinical chemistry industry. Growing awareness of the importance of diagnostic tests and rising disposable incomes are driving demand in the clinical chemistry industry.

Restraints/Challenges

Unavailability of skilled professionals along with high cost of devices will hamper the growth of the clinical chemistry market in the mentioned forecast period.

This clinical chemistry market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clinical chemistry market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Clinical Chemistry Market

The COVID-19 epidemic had a negative impact on the companies' sales. Lockdowns arising from the COVID-19 epidemic forced people to put off getting their health checked, reducing the amount of tests performed and reagent sales. However, as governments gradually loosen travel restrictions, there is a rebound in testing numbers. With the COVID-19 pandemic, dealing with infectious diseases has become a major medical concern around the world. In addition to vaccinations and therapeutic medications, there is an increasing demand for more precise and simple testing technologies as well as the expansion of testing structures.

Recent Development

• 2019 年 1 月 – 霍夫曼-拉-罗氏公司发布了血清工作区集成解决方案 COBAS PRO。这是实验室诊断领域的一个重大里程碑，因为它每小时可以进行 2,200 次测试。
• 2019年2月 ——富士胶片株式会社与日本电子在国际临床化学分析仪市场建立战略合作伙伴关系。

全球临床化学 市场范围

临床化学市场根据产品类型、应用和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

产品类型

• 临床化学分析仪
• POC 测试套件
• 临床化学分析仪试剂盒和试剂

 应用

• 基本代谢物面板
• 肝功能检查
• 电解质面板
• 肾功能检查
• 血脂状况
• 特种化学品测试
• 甲状腺检查
• 其他生化测试

终端用户

• 医院
• 病理实验室
• 产科中心
• 门诊中心
• 诊所

临床化学 市场区域分析/见解

对临床化学市场进行了分析，并按国家、产品类型、应用和最终用户提供了市场规模洞察和趋势，如上所述。

临床化学市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于老年人口的不断增长以及创新医疗技术的采用，北美在临床化学市场占据主导地位。

由于健康意识的增强和对先进医疗技术的需求不断增长，预计亚太地区将在 2022 年至 2029 年的预测期内以最高的增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和临床化学 市场份额分析

临床化学市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对临床化学市场的关注有关。

临床化学市场的一些主要参与者包括：

• 雅培（美国）
• 丹纳赫（美国）
• Thermo Fisher Scientific Inc.（美国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• 强生服务公司（美国）
• 西门子(德国)
• ELI科技集团（法国）
• HORIBA株式会社（日本）
• 深圳迈瑞生物医疗电子股份有限公司 (中国)
• Randox Laboratories Ltd.（英国）
• Ortho Clinical Diagnostics（美国）
• Nova Biomedical（美国）
• Sysmex 公司 (日本)
• Bio Systems Diagnostics Pvt. Ltd.（印度）
• DiaSys Diagnostic Systems GmbH（德国）
• Endress Hauser Management AG（瑞士）
• Diatron（匈牙利）
• SFRI.（法国）
• EKF Medica 公司（英国）

SKU-53044